Publication | Open Access
Timing variability and midfrontal ~4 Hz rhythms correlate with cognition in Parkinson’s disease
20
Citations
48
References
2020
Year
Unknown Venue
NeuropsychologyBrain FunctionNeurophysiological BiomarkersSocial SciencesParkinson ’Cognitive ElectrophysiologyNeurologyCognitive NeuroscienceHealth SciencesNeuropsychological FunctioningCognitive ScienceInterval TimingMontreal Cognitive AssessmentSensorimotor IntegrationNeuroimagingCognitive FunctionNeurological AssessmentPd PatientsMovement DisordersCognitive PerformanceNeurophysiologyCognitive DynamicsEeg Signal ProcessingHuman NeuroscienceNeuroscienceBrain ElectrophysiologyTime Perception
ABSTRACT Patients with Parkinson’s disease (PD) can have significant cognitive dysfunction; however, the mechanisms for these cognitive symptoms are unknown. Here, we used scalp electroencephalography (EEG) to investigate the cortical basis for PD-related cognitive impairments during interval timing, which requires participants to estimate temporal intervals of several seconds. Time estimation is an ideal task demand for investigating cognition in PD because it is simple, requires medial frontal cortical areas, and recruits basic executive processes such as working memory and attention. However, interval timing has never been systematically studied in PD patients with cognitive impairments. We report three main findings. First, 71 PD patients had increased temporal variability compared to 37 demographically-matched controls, and this variability correlated with cognitive dysfunction as measured by the Montreal Cognitive Assessment (MOCA). Second, PD patients had attenuated ~4 Hz EEG oscillatory activity at midfrontal electrodes in response to the interval-onset cue, which was also predictive of MOCA. Finally, trial-by-trial linear mixed-effects modeling demonstrated that cue-triggered ~4 Hz power predicted subsequent temporal estimates as a function of PD and MOCA. Our data suggest that impaired cue-evoked midfrontal ~4 Hz activity predicts increased timing variability that is indicative of cognitive dysfunction in PD. These findings link PD-related cognitive dysfunction with cortical mechanisms of cognitive control, which could advance novel biomarkers and neuromodulation for PD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1